New Zealand pharma company Rua Bioscience said it has received a Good Manufacturing Practice (GMP) certification from Medsafe, the medicines and medical devices safety authority that is a part of the New Zealand Ministry of Health. Rua said the certification will let it begin to make its first medicinal cannabis product, a CBD oil. The company will now submit a New Medicinal Cannabis Product Application to the Medicinal Cannabis Agency, which will undertake an assessment against Minimum Quality Standards. Rua Bioscience, based in Tairāwhiti, is listed on the NZX, New Zealand’s national stock exchange.
NZ company to make CBD
Support HempToday with a donation
We appreciate our paying subscribers and strive to deliver the most complete, well-researched and comprehensive news, analysis and commentary about the hemp industries. If you’d like to further support us, click below to make a donation.